See Our Winners, Runners Up & Shortlisted

The 2026 winners and runners-up were announced during a special ceremony taking place at the 17th World ADC San Diego.

Best ADC Platform Technology

Winner:

ConjuAll
LigaChem Biosciences
Runner Up:

GlycoConnect
Lonza

Shortlisted:

  • AJICAP – Ajinomoto Bio-Pharma Services
  • ConjuAll – LigaChem Biosciences
  • GlycoConnect – Lonza
  • TMALIN – MediLink Therapeutics
  • WuXi DARx – WuXi XDC
Best New ADC Drug Developer

Winner:

Callio Therapeutics

Runner Up:
Kivu Bioscience

 

Shortlisted:

  • Aarvik Therapeutics
  • Callio Therapeutics
  • Kivu Bioscience
  • Valink Therapeutics
Most Promising ADC to Watch

Winner:

IKS014

Iksuda Therapeutics & Fosun Pharma


Runner Up:

Emiltatug ledadotin

Mersana Therapeutics

Shortlisted:

  • DS3939a - Daiichi Sankyo
  • Emiltatug ledadotin (Emi-Le) - Servier
  • JK06 - Salubris Biotherapeutics
  • Mocertatug rezetecan (Mo-Rez) - GSK & Hansoh Pharma
  • Puxitatug Samrotecan - AstraZeneca
  • Sofetabart Mipitecan - Eli Lilly
  • TUB-040 - Gilead & Tubulis
Best ADC Clinical Impact

Winner:

Izalontamab brengitecan (Iza-bren)

BMS & SystImmune


Runner Up:

HER3-DXd

Daiichi Sankyo & Merck

Shortlisted:

  • Izalontamab brengitecan (Iza-bren) – BMS & SystImmune
  • HER3-DXd – Daiichi Sankyo & Merck
  • IKS014 – Iksuda Therapeutics & Fosun Pharma
Best CDMO

Winner:

WuXi XDC

Runner Up:

BSP Pharmaceuticals

Shortlisted:

  • Abzena
  • AsymBio
  • Axplora
  • BSP Pharmaceuticals
  • Lonza
  • MilliporeSigma
  • Piramal Pharma Solutions
  • WuXi XDC
Best CRO

Winner:

WuXi XDC

Runner Up:

NJ Bio

Shortlisted:

  • Charles River Laboratories
  • ChemExpress
  • Crown Biosciences
  • NJ Bio
  • WuXi XDC
Best Up & Coming Solution Provider

Winner:

LIDE Biotech

Runner Up:

HUB Organoids

 

 

Shortlisted:

  • HUB Organoids
  • LIDE Biotech
  • LOTTE Biologics
  • Sygnature Discovery
  • Turbine
  • Xcellon Biologics
Best Preclinical Publication 2025

Winner:

Effective Extracellular Payload Release and Immunomodulatory Interactions Govern the Therapeutic Effect of Trastuzumab Deruxtecan 

Runner Up:

XMT-2056, a HER2-Directed STING Agonist ADC, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells 

Best Poster 2026

Winner:

 

Outstanding Academic Investigator Award

Winner:

Edward Tate
Imperial College London

The George R. Pettit Individual Input to the Field 2025

Winner:

Dominik Schumacher

The Toshinori Agatsuma Long Standing Contribution to the Field Award

Winner:

Gail Lewis

World ADC Awards 2025
World ADC Awards 2025
World ADC Awards 2025
Screenshot-2026-04-29-170158-768x507
Explore World ADC San Diego's Agenda

Discover the latest industry breakthroughs and insights to be shared at the biggest ADC event, ahead of the awards' gala.

Screenshot-2026-04-29-170322-768x494
Partner With Us

Position yourself in front of the pioneers trailblazing ADCs to standard of care treatments.

World ADC Awards 2025
View the 2025 Shortlisted

Have a look at the shortlisted candidates to be recognized this year because of their exceptional work propelling the ADC field to new heights.